MEAGAN GRUWELL: Open Payments
NPI 1386429934 · SCOTTSDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,860 in 136 payments from 34 companies in 2025. Trend: 2023 $498 · 2024 $4,018 · 2025 $2,860
Food & beverage: $2,818Education: $43
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 11 | $360 |
| Amgen Inc. | 17 | $264 |
| Lilly USA, LLC | 15 | $255 |
| Novo Nordisk Inc | 20 | $249 |
| Insulet Corporation | 10 | $203 |
| BETA BIONICS, INC. | 7 | $171 |
| SANOFI-AVENTIS U.S. LLC | 6 | $169 |
| AstraZeneca Pharmaceuticals LP | 6 | $158 |
| Dexcom, Inc. | 3 | $92 |
| Amneal Pharmaceuticals LLC | 5 | $89 |
Products named: Kerendia, Omnipod, REPATHA, iLet Bionic Pancreas, TZIELD, FARXIGA, Ozempic, JARDIANCE.
Industry payments across AZ — which companies pay providers there.
